Risperidone augmentation decreases rapid eye movement sleep and decreases wake in treatment-resistant depressed patients.

BACKGROUND: The atypical antipsychotic agent risperidone has beneficial effects on mood in patients with schizophrenia. This study aimed to assess whether risperidone produced typical antidepressant-like effects in the polysomnogram of healthy subjects and in depressed patients unresponsive to anti...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak: Sharpley, A, Bhagwagar, Z, Hafizi, S, Whale, W, Gijsman, H, Cowen, P
Formatua: Journal article
Hizkuntza:English
Argitaratua: 2003